scPharmaceuticals Inc.
SCPHUnlisted companyscPharmaceuticals Inc. in brief
scPharmaceuticals Inc. is an unlisted company in the Biotechnology industry, based in Massachusetts, USA. It was founded in 2013. In the year to Dec 2020 it had sales of $0 M and a net loss of $32 M.
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
scPharmaceuticals Inc. timeline
- 2013
- 🏁· approximateFounded
- 2017
- 🔔· approximateInitial public offering on Nasdaq
Events of scPharmaceuticals Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about scPharmaceuticals Inc.
- Acquisitions and changes
- No longer listed: ticker SCPH is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #3,637 (Jan 2020) · #3,451 (Jan 2021) · #4,192 (Jan 2022) · #3,623 (Dec 2022) · #3,215 (Jul 2023) · #3,147 (Jan 2024)
Annual results
- Revenue
- $0 M
- Operating income
- —
- Net income
- $-32 M
Dec-2020 ending year
Mutual funds holding scPharmaceuticals Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 The Gabelli ABC FundGabelli Funds, LLC | 22,000 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
As of Jun 30, 2026
Markets and events: scPharmaceuticals Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2025-10-06 23:50 UTC, code D, resumed 04:00 UTC
- 2025-08-25 11:25 UTC, code T3, resumed 12:00 UTC
Fails to deliver
- : 2 shares at $5.67
- : 22 shares at $5.63
- : 400 shares at $5.63
- : 2 shares at $5.62
- : 310 shares at $5.61
Lobbying by scPharmaceuticals Inc.#
$50 K spent on lobbying the US Congress and federal agencies in 2025, most often on medicare/medicaid and health issues.
- Medicare/Medicaid4 reports
- Health Issues4 reports
Lobbying firms hired in 2025
JEFFREY J. KIMBELL AND ASSOCIATES $50 K
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2026 (so far) | $13 K | — | 1 |
| 2025 | $50 K | — | 4 |
| 2024 | $50 K | — | 4 |
| 2023 | $13 K | — | 1 |
H-1B hiring at scPharmaceuticals Inc.#
2 labor condition applications certified in fiscal 2024 for 2 positions, at a median wage of $124 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Manager, Medical Affairs & PharmacovigilanceCompliance Managers | 1 | $126 K |
| Regulatory Affairs ManagerRegulatory Affairs Managers | 1 | $121 K |
Where: Burlington, MA 2
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2024 | 2 | 2 | $124 K | 2 |
| FY2021 | 2 | 2 | $87 K | 2 |
How scPharmaceuticals Inc. compares in Biotechnology
- Revenue$0 M · higher than 0% of 647
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| scPharmaceuticals Inc.🇺🇸 | $228 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
How current the figures are
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- Dec-2020 ending year
- Balance sheet:
- Dec-2020 ending year
- Profile updated:
- Nov 14, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at scPharmaceuticals Inc.? Verify and update this profile — free
Show scPharmaceuticals Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.